cancer - Nursing Case Study

Pathophysiology

• Primary mechanism: Uncontrolled Cell Proliferation - Cancer begins with genetic mutations that disrupt normal cell cycle regulation, leading to unchecked cell division and tumor formation. These mutations can activate oncogenes or inactivate tumor suppressor genes, crucial for cell growth control.

• Secondary mechanism: Evasion of Apoptosis - Cancer cells evade programmed cell death, allowing them to survive longer than normal cells. This evasion is often due to mutations in genes that regulate apoptosis, enabling the accumulation of abnormal cells.

• Key complication: Metastasis - Cancer cells can invade surrounding tissues and spread to distant organs through blood or lymphatic systems. This dissemination often complicates treatment and is a primary cause of cancer mortality, highlighting the importance of early detection and intervention.

Patient Profile

Demographics:

58-year-old male, retired factory worker

History:

• Key past medical history: Hypertension, Type 2 Diabetes, Former smoker (20 pack-years)

• Current medications: Metformin 500 mg BID, Lisinopril 10 mg daily, Aspirin 81 mg daily

• Allergies: Penicillin

Current Presentation:

• Chief complaint: Persistent cough and shortness of breath

• Key symptoms: Fatigue, weight loss, occasional hemoptysis, mild chest pain

• Vital signs: Blood pressure 145/90 mmHg, heart rate 105 bpm, respiratory rate 22 breaths per minute, temperature 99.1°F, oxygen saturation 90% on room air

Section 1

New Diagnostic Results:

Following the initial assessment, the healthcare team ordered a series of diagnostic tests to further evaluate the patient's condition. A chest X-ray revealed a suspicious mass in the right upper lobe of the lung, prompting a CT scan for more detailed imaging. The CT scan confirmed the presence of a 4.5 cm mass with irregular borders, suggestive of malignancy, and identified enlarged hilar lymph nodes, raising concern for potential metastasis. A subsequent bronchoscopy with biopsy was performed, yielding tissue samples that were sent for histopathological examination.

The biopsy results revealed non-small cell lung cancer (NSCLC), specifically adenocarcinoma, a common type seen in former smokers. Further PET-CT imaging was conducted to assess for metastatic spread, revealing increased metabolic activity not only in the lung mass but also in the mediastinal lymph nodes and a small lesion in the left adrenal gland. These findings indicate a likely stage IV cancer, suggesting distant metastasis and significantly impacting the treatment plan and prognosis.

This diagnosis necessitates a multidisciplinary approach involving oncology, pulmonology, and palliative care teams to discuss potential treatment options including chemotherapy, targeted therapy, and possible immunotherapy. The patient's comorbidities, such as hypertension and diabetes, must be carefully managed alongside cancer treatment to optimize overall health and quality of life. As the team formulates a comprehensive care plan, discussions with the patient and his family regarding goals of care and potential participation in clinical trials will be crucial in guiding the next steps of his cancer journey.

Section 2

New Complications:

Several weeks into the patient's treatment regimen, which included a combination of chemotherapy and targeted therapy, he began experiencing new symptoms that raised concerns about emerging complications. The patient reported increasing fatigue, shortness of breath, and a persistent cough, which were initially attributed to the side effects of chemotherapy. However, a more thorough clinical assessment revealed additional findings that warranted further investigation.

During a routine follow-up clinic visit, the nurse noted that the patient appeared visibly pale and had mild tachypnea with a respiratory rate of 24 breaths per minute. His vital signs showed a blood pressure of 145/90 mmHg, a heart rate of 110 bpm, and an oxygen saturation of 88% on room air. A complete blood count was ordered, revealing a hemoglobin level of 9.2 g/dL and a white blood cell count of 15,000/mm³, indicating possible anemia and leukocytosis. Given these findings, further diagnostic tests, including a chest X-ray and arterial blood gases, were performed to assess the underlying cause of his respiratory symptoms.

The chest X-ray indicated bilateral pleural effusions, more pronounced on the right side, which were likely contributing to the patient's dyspnea. An echocardiogram was also performed, revealing reduced left ventricular ejection fraction, suggesting the development of cardiomyopathy, potentially induced by the chemotherapy. These complications prompted the healthcare team to adjust the patient's treatment plan, focusing on managing the pleural effusions through thoracentesis and considering cardioprotective strategies to address the cardiac issues. Additionally, discussions regarding the potential modification of his cancer treatment regimen were initiated to prevent further cardiac compromise, highlighting the need for ongoing monitoring and interdisciplinary collaboration in managing his complex condition.

Section 3

Response to Interventions:

Following the initial management of the patient's pleural effusions and cardiac concerns, the healthcare team closely monitored his response to the interventions. The thoracentesis successfully alleviated some of the patient's dyspnea, and his oxygen saturation improved to 92% on room air post-procedure. The patient reported a slight reduction in cough and felt more comfortable breathing. Additionally, the cardioprotective strategy, which included the introduction of beta-blockers and ACE inhibitors, was initiated with the aim of stabilizing his cardiac function. Over the next few days, the patient's heart rate decreased to 95 bpm, and his blood pressure stabilized at 130/85 mmHg, indicating a positive initial response to the cardiac interventions.

However, despite these improvements, the patient continued to experience significant fatigue, and his hemoglobin level remained low, prompting the healthcare team to consider erythropoiesis-stimulating agents to address the anemia. A repeat complete blood count showed a slight increase in white blood cell count to 16,500/mm³, raising concerns about an underlying inflammatory or infectious process. Given these findings, the team decided to conduct further investigations, including blood cultures and a comprehensive metabolic panel, to rule out infection and assess the patient's overall metabolic status. Additionally, the oncology team considered modifying the chemotherapy regimen to mitigate potential adverse effects on the patient's cardiac and hematologic systems, highlighting the ongoing need for a dynamic and interdisciplinary approach to his treatment.

These developments underscored the complexity of managing cancer patients with emerging complications, emphasizing the importance of vigilant monitoring and prompt adaptation of therapeutic strategies. As the medical team prepared for the next steps, they remained attentive to the patient's evolving condition, ensuring each decision was informed by the latest clinical data and aimed at optimizing his quality of life while effectively targeting the cancer.

Section 4

New Complications:

Despite initial improvements, the patient's condition began to deteriorate, manifesting as a sudden increase in respiratory distress and a new onset of confusion. On examination, his respiratory rate increased to 28 breaths per minute, and auscultation revealed diminished breath sounds on the right side, suggesting the possibility of fluid re-accumulation or a new pleural effusion. Oxygen saturation dropped to 88% on room air, necessitating supplemental oxygen to maintain adequate levels. Concurrently, the patient exhibited signs of altered mental status, with increased irritability and difficulty concentrating, raising concerns about potential hypoxemia or an evolving metabolic imbalance.

New diagnostic results added further complexity to the clinical picture. Blood cultures returned positive for Staphylococcus epidermidis, indicating a bloodstream infection likely related to an indwelling device. The comprehensive metabolic panel showed a marked increase in creatinine to 2.3 mg/dL, suggesting acute kidney injury, possibly secondary to both sepsis and the nephrotoxic effects of ongoing chemotherapy. These findings prompted a reevaluation of the treatment strategy, focusing on the urgent management of the infection with broad-spectrum antibiotics and careful monitoring of renal function.

The healthcare team recognized the need for immediate intervention to address these new complications. A decision was made to temporarily halt chemotherapy to reduce the risk of further renal damage and to focus on stabilizing the patient's condition. The interdisciplinary team, including infectious disease specialists, nephrologists, and oncologists, collaborated closely to develop a cohesive care plan aimed at resolving the infection, supporting renal function, and reassessing the cancer treatment strategy. The patient's complex condition highlighted the critical importance of integrated care and continuous reassessment, ensuring that each therapeutic decision was evidence-based and patient-centered, with the ultimate goal of improving his overall health and quality of life.

Section 5

Change in Patient Status:

Following the targeted interventions for the patient's complications, there was a noticeable change in his clinical status. After initiating broad-spectrum antibiotics, the patient's fever began to subside, and his white blood cell count started to normalize, indicating a positive response to the treatment for the bloodstream infection. However, the patient continued to experience respiratory distress despite being on supplemental oxygen, with oxygen saturation fluctuating between 90-92% on 4 liters via nasal cannula. A repeat chest X-ray was conducted, revealing an increase in the size of the pleural effusion on the right side, confirming that the fluid accumulation was contributing to the ongoing respiratory issues.

In light of these findings, the healthcare team decided to proceed with a therapeutic thoracentesis to relieve pressure and improve lung expansion. Post-procedure, the patient reported a significant decrease in respiratory discomfort, and his oxygen saturation improved to 95% on 2 liters of oxygen. Despite these improvements, his mental status remained concerning. The patient continued to exhibit confusion and irritability, although his glucose levels and electrolytes were within normal limits, ruling out common metabolic causes.

A neurological consultation was requested to explore other reasons for the altered mental status, such as metastasis to the brain or paraneoplastic syndromes. The interdisciplinary team discussed the possibility of imaging studies to further investigate these concerns. As the patient stabilized in some areas, the focus turned to understanding the broader implications of his cancer progression on this new development, prompting a re-evaluation of his overall treatment plan. The team emphasized the need for ongoing monitoring and dynamic adjustments to his care regimen, ensuring that each step was aligned with his evolving clinical picture and personal wishes.